KER-012 Prevents Heart Damage in PH Mice

KER-012 Prevents Heart Damage in PH Mice

312186

KER-012 Prevents Heart Damage in PH Mice

Treatment with the experimental medication KER-012 helped to prevent heart damage in a mouse model of pulmonary hypertension, new research shows. The findings were showcased by KER-012’s developer, Keros Therapeutics, at the American Heart Association (AHA) 2021 Scientific Sessions, held Nov. 13–15, according to a company press release. KER-012 is designed to increase the activity of a molecular signaling cascade called the bone morphogenic protein (BMP) pathway. As its name suggests, this pathway is important for bone…

You must be logged in to read/download the full post.